QA: Aquestive Therapeutics Inc. in us_pharma/2019

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001398733_2020_Aquestive_Therapeutics_Inc.pdf

Logs

info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0001398733, Aquestive Therapeutics Inc.

  xvar xval
0 AssetsCurrent 68,314,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 9,726,000
3 remainder_Assets 439,000
4 LiabilitiesCurrent 18,555,000
5 LiabilitiesNoncurrent 4,348,000
6 remainder_Liabilities 61,698,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 64,342,000
9 ResearchAndDevelopmentExpense 20,574,000
10 remainder_Expenses 29,679,000
11 remainder_Revenues 53,245,000
12 remainder_NetIncome -4,896,000
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 78,479,000
1 Liabilities 84,601,000
2 Expenses 114,595,000
3 Revenues 53,245,000
4 StockholdersEquity -6,122,000
5 NetIncome -66,246,000
6 ComprehensiveNetIncome -66,246,000
7 BaseVar 167,908,000
8 EconomicCapitalRatio -0.942

Edgar->Model Mapping

Feature Distribution

Change over Time